Invasive ductal carcinoma with a predominant intraductal component

MicroRNA profiles transition from normal breast to ductal carcinoma in situ and transition to invasive ductal carcinoma (IDC) and methods of use thereof are described.

Infiltrating or invasive ductal carcinoma accounts for about 80 percent of all breast cancers.

Tubular invasive ductal carcinoma is less likely to come back after treatment.

All of these different types of invasive ductal carcinoma are treated in the same way.

Most men with breast cancer have “infiltrating ductal carcinoma” and other types of breast cancer are very rare.